Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omnicare’s Bid for NeighborCare Gets FTC Approval

This article was originally published in The Pink Sheet Daily

Executive Summary

Institutional pharmacy provider Omnicare raises its hostile takeover bid for NeighborCare to $1.7 bil. the same day FTC announced the close of its investigation. The commission emphasized the effect of Medicare Part D on the institutional pharmacy provider market in approving the merger.

You may also be interested in...



Omnicare And NeighborCare Reach $1.8 Bil. Merger Agreement

NeighborCare agrees to Omnicare's latest offer announced July 5, ending over a year of takeover overtures. The merger is expected to close during the third quarter.

Omnicare And NeighborCare Reach $1.8 Bil. Merger Agreement

NeighborCare agrees to Omnicare's latest offer announced July 5, ending over a year of takeover overtures. The merger is expected to close during the third quarter.

Omnicare Boosts Specialty Pharma Services With $235 Mil. RxCrossroads Buy

Acquisition will enable company to leverage "end-to-end" product development through post-commercialization offerings, company says. Omnicare is now in discussions with NeighborCare after raising its takeover bid to $1.55 bil.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062408

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel